var data={"title":"Idiopathic intracranial hypertension (pseudotumor cerebri): Epidemiology and pathogenesis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Idiopathic intracranial hypertension (pseudotumor cerebri): Epidemiology and pathogenesis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/contributors\" class=\"contributor contributor_credentials\">Andrew G Lee, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/contributors\" class=\"contributor contributor_credentials\">Michael Wall, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/contributors\" class=\"contributor contributor_credentials\">Paul W Brazis, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/contributors\" class=\"contributor contributor_credentials\">Janet L Wilterdink, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 25, 2015.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Idiopathic intracranial hypertension (IIH) is also commonly called pseudotumor cerebri. It is a disorder defined by clinical criteria that include symptoms and signs isolated to those produced by increased intracranial pressure (eg, headache, papilledema, vision loss), elevated intracranial pressure with normal cerebrospinal fluid composition, and no other cause of intracranial hypertension evident on neuroimaging or other evaluations [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/1\" class=\"abstract_t\">1</a>].</p><p>While once called benign intracranial hypertension, to distinguish it from secondary intracranial hypertension produced by a neoplastic malignancy, it is not a benign disorder. Many patients suffer from intractable, disabling headaches, and there is a risk of severe, permanent vision loss.</p><p>While the pathogenesis of IIH is unknown, risk factors have been identified and many theories advanced as to its cause. The epidemiology and pathogenesis of IIH will be reviewed here. The clinical features, diagnosis, prognosis, and treatment of this disorder are discussed separately. (See <a href=\"topic.htm?path=idiopathic-intracranial-hypertension-pseudotumor-cerebri-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis&quot;</a> and <a href=\"topic.htm?path=idiopathic-intracranial-hypertension-pseudotumor-cerebri-prognosis-and-treatment\" class=\"medical medical_review\">&quot;Idiopathic intracranial hypertension (pseudotumor cerebri): Prognosis and treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span></p><p class=\"headingAnchor\" id=\"H456571163\"><span class=\"h2\">Incidence</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The annual incidence of IIH is 1 to 2 per 100,000 population [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/2,3\" class=\"abstract_t\">2,3</a>]. There is a higher incidence in obese women between the ages of 15 and 44 years (4 to 21 per 100,000) [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/3,4\" class=\"abstract_t\">3,4</a>]. With the increasing obesity epidemic in the United States and in other parts of the world, the incidence and prevalence of IIH is rising [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/5\" class=\"abstract_t\">5</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>IIH is a disorder that primarily affects women of childbearing age who are overweight [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/3,4,6-10\" class=\"abstract_t\">3,4,6-10</a>]. In a prospective study of 50 consecutively-diagnosed IIH patients, 92 percent were women with a mean age of 31 years (range 11 to 58 years) and 94 percent were obese [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/9\" class=\"abstract_t\">9</a>]. Other case series in different geographic areas and ethnic groups report consistent findings [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/4,10-15\" class=\"abstract_t\">4,10-15</a>].</p><p>IIH can also occur in males, in children as young as four months, in older patients (up to 88 years), and in patients who are not overweight [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/14,16-19\" class=\"abstract_t\">14,16-19</a>]. However, when symptoms occur in one of the less typical patient groups, the evaluation for secondary causes of intracranial hypertension is particularly important. (See <a href=\"topic.htm?path=idiopathic-intracranial-hypertension-pseudotumor-cerebri-clinical-features-and-diagnosis#H12\" class=\"medical medical_review\">&quot;Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis&quot;, section on 'Differential diagnosis'</a>.)</p><p>Risk factors are somewhat different in prepubertal children compared with adults. The gender difference is not as apparent [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/16,20-28\" class=\"abstract_t\">16,20-28</a>]. Also, prepubertal children with IIH are not more likely to be obese than the general age-matched population [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/20,21,24,25,27,28\" class=\"abstract_t\">20,21,24,25,27,28</a>]. In one report, older patients (44 to 88 years) with IIH were also more often male and less often obese than IIH patients in the more typical age range [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/29\" class=\"abstract_t\">29</a>]. Men with IIH have a similar age distribution as women, and obesity remains a risk factor but may be less prevalent than in women with IIH [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/11,17\" class=\"abstract_t\">11,17</a>].</p><p>Recent weight gain may be a risk factor for IIH, according to case-control studies [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/7,9,10,30\" class=\"abstract_t\">7,9,10,30</a>]. In one series, there was an average reported weight gain of 1.8 kg over the two months preceding symptom onset [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/9\" class=\"abstract_t\">9</a>]; in another, there was an average 20 lb weight gain over the preceding year compared to an average weight loss of 1.2 lb in controls [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/10\" class=\"abstract_t\">10</a>].</p><p>In the Idiopathic Intracranial Hypertension Treatment Trial, (IIHTT), five percent of patients reported a family history of IIH [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/15\" class=\"abstract_t\">15</a>]. As this is higher than the prevalence of IIH in obese persons, a genetic component for IIH is speculated.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Associated conditions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although IIH is, by definition, idiopathic, a number of systemic diseases, drugs, vitamin deficiencies and excesses, and hereditary conditions have been reported to be associated with IIH. Most patients with IIH do not have one of these conditions.</p><p>The true link between these conditions and IIH is uncertain in many cases. In case-control studies, the prevalence of menstrual irregularities, pregnancy, antibiotic use, iron deficiency anemia, thyroid dysfunction, and oral contraceptive use were no different among cases versus controls [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/7,10\" class=\"abstract_t\">7,10</a>]. However, these studies were small (40 to 50 patients), which may have limited their ability to detect true associations.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Medications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of medications and other exogenous substances have been linked to IIH. For some of these, the connection may be anecdotal. In other cases, evidence that supports a true association includes temporal proximity between drug initiation and IIH in a substantial number of patients, resolution with drug cessation or dose-lowering, lack of recurrence off medication, <span class=\"nowrap\">and/or</span> reemergence of IIH with drug rechallenge. Such evidence appears to exist for growth hormone, tetracyclines, and retinoids.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Growth hormone appears to be associated with IIH in a dose-related manner [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/31-37\" class=\"abstract_t\">31-37</a>]. One 2007 study estimated the incidence of IIH in children treated with GH to be 27.7 per 100,000 treatment years. This complication usually develops within one year of initiation of therapy, but may appear after several years of treatment [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/38\" class=\"abstract_t\">38</a>]. IIH generally subsides with stopping growth hormone therapy; resuming at a lower dose is often successful. Other specific treatments for IIH may also be required [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/35\" class=\"abstract_t\">35</a>]. (See <a href=\"topic.htm?path=treatment-of-growth-hormone-deficiency-in-children\" class=\"medical medical_review\">&quot;Treatment of growth hormone deficiency in children&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tetracyclines, including <a href=\"topic.htm?path=minocycline-drug-information\" class=\"drug drug_general\">minocycline</a> and <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> have been linked in a number of cases to IIH, but other risk factors are often present [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/39-48\" class=\"abstract_t\">39-48</a>]. When it occurs, IIH often appears shortly after onset of treatment (within a few weeks to months), but a more delayed-onset has been described. Drug withdrawal appears to be sufficient for treatment in some, but not all patients.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypervitaminosis A from excessive dietary intake has been a long-known cause of IIH [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/39,49\" class=\"abstract_t\">39,49</a>]. Other retinoids used in the treatment of dermatologic conditions and cancer therapy, all-trans-retinoic acid, retinol, <a href=\"topic.htm?path=isotretinoin-drug-information\" class=\"drug drug_general\">isotretinoin</a>, etretinate, and tretinoin have also been reported to be associated with IIH [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/39,40,44,50-54\" class=\"abstract_t\">39,40,44,50-54</a>].</p><p/><p>More limited, possibly anecdotal evidence link other medications with IIH:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Thyroid replacement [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/23,55-57\" class=\"abstract_t\">23,55-57</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Corticosteroid withdrawal [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/29,58,59\" class=\"abstract_t\">29,58,59</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=lithium-drug-information\" class=\"drug drug_general\">Lithium</a> [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/60-63\" class=\"abstract_t\">60-63</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nalidixic acid [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/24,64\" class=\"abstract_t\">24,64</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=nitrofurantoin-drug-information\" class=\"drug drug_general\">Nitrofurantoin</a> [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/65,66\" class=\"abstract_t\">65,66</a>]</p><p/><p/><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Systemic illnesses</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to obesity, systemic illnesses reportedly associated with IIH include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Addison disease [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/67,68\" class=\"abstract_t\">67,68</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypoparathyroidism [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/69\" class=\"abstract_t\">69</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anemia, usually severe [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/14,70-72\" class=\"abstract_t\">14,70-72</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sleep apnea [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/14,15,18,73,74\" class=\"abstract_t\">14,15,18,73,74</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Systemic lupus erythematosus (SLE) [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/75-77\" class=\"abstract_t\">75-77</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Behcet's syndrome [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/78,79\" class=\"abstract_t\">78,79</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Polycystic ovary syndrome [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/80\" class=\"abstract_t\">80</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Coagulation disorders [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/80-83\" class=\"abstract_t\">80-83</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Uremia [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/84\" class=\"abstract_t\">84</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypovitaminosis A [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/85-88\" class=\"abstract_t\">85-88</a>]</p><p/><p>The pathogenic mechanisms associating these conditions with IIH are uncertain and in some cases the apparent association may be indirect or spurious. As examples, polycystic ovary syndrome and sleep apnea are associated with obesity and therefore may be secondarily associated with IIH. In SLE, cases of apparent IIH may be due to occult cerebral venous thrombosis (related to inflammation of the venous sinus or hypercoagulability) or to corticosteroid withdrawal [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/75\" class=\"abstract_t\">75</a>]. Other hypercoagulable syndromes, sarcoidosis, and Behcet's may also be associated with IIH by causing secondary intracranial hypertension via occult venous sinus thrombosis. (See <a href=\"topic.htm?path=idiopathic-intracranial-hypertension-pseudotumor-cerebri-clinical-features-and-diagnosis#H12\" class=\"medical medical_review\">&quot;Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis&quot;, section on 'Differential diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although many theories for IIH have been proposed, the precise pathogenesis of IIH remains unknown. Any theory must account for the high incidence of IIH in obese women of the childbearing years. Proposed etiologies include cerebral venous outflow abnormalities (eg, venous stenoses and venous hypertension); increased cerebrospinal fluid (CSF) outflow resistance at either the level of the arachnoid granulations or CSF lymphatic drainage sites; obesity-related increased abdominal and intracranial venous pressure; altered sodium and water retention mechanisms; and abnormalities of <a href=\"topic.htm?path=vitamin-a-drug-information\" class=\"drug drug_general\">vitamin A</a> metabolism [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/89\" class=\"abstract_t\">89</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Intracranial venous hypertension</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Elevated intracranial venous pressure is postulated both as a primary mechanism and as a &quot;final common pathway&quot; for IIH. This theory is supported by the similar clinical appearances of IIH and secondary intracranial hypertension due to cerebral venous thrombosis and other causes of obstructed venous outflow. Some patients thought to have IIH have been later discovered to have one of these conditions [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/78,90-92\" class=\"abstract_t\">78,90-92</a>]. (See <a href=\"topic.htm?path=idiopathic-intracranial-hypertension-pseudotumor-cerebri-clinical-features-and-diagnosis#H12\" class=\"medical medical_review\">&quot;Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis&quot;, section on 'Differential diagnosis'</a>.)</p><p>Although several authors have reported cerebral venous outflow abnormalities on magnetic resonance imaging (MRI) and MR venography (MRV) in patients with IIH, there is some disagreement as to the frequency or the significance of these findings [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/19,93,94\" class=\"abstract_t\">19,93,94</a>]. Clear venous sinus thrombosis has definite clinicopathologic significance, but apparent venous sinus narrowing or stenosis may not [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/95\" class=\"abstract_t\">95</a>]. Differentiation of venous stenosis from flow related abnormalities, especially on non-contrast MRV, can be difficult as flow-related artifacts can mimic venous sinus stenoses or even be mistaken for sinus thrombosis. These can sometimes be resolved with post-contrast MRV. Literature that suggests a high frequency of venous sinus abnormalities in patients with IIH must be viewed with caution.</p><p>Cerebral venous sinus structural abnormalities were systematically identified in a series of 29 patients with IIH using a specialized MR venography technique, auto-triggered elliptic-centric-ordered three-dimensional gadolinium-enhanced MR venography (ATECO MRV) [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/96\" class=\"abstract_t\">96</a>]. Blinded readers detected substantial bilateral sinovenous stenoses in 27 of 29 patients compared with 4 of 59 controls, corresponding to a sensitivity and specificity of 93 percent. The investigators speculated that congenital narrowing of the venous sinus might be a primary cause of IIH or instead may be a secondary, but potentially contributing factor. In the latter scenario, increased CSF pressure compresses the transverse sinus leading to the stenosis, which in turn would exacerbate the increased intracranial pressure (ICP), potentially bringing the patient to clinical presentation.</p><p>Other evidence conflicts as to whether these apparent venous abnormalities are a secondary versus a primary or causative phenomenon. One study documented high intracranial venous sinus pressures in patients with IIH that was reduced by removal of CSF [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/97\" class=\"abstract_t\">97</a>]. This finding implies that increased cerebral venous sinus pressure and apparent stenosis in IIH is caused by the elevated ICP and not the reverse. Other reports have also documented reversal of apparent transverse sinus stenosis after CSF shunting [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/98-103\" class=\"abstract_t\">98-103</a>]. In contrast, other case series have documented persistent transverse sinus stenosis in patients with IIH whose CSF pressure normalized, and overall poor correlation between the severity of the venous abnormalities and the degree of pressure elevation or severity of clinical findings [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/104,105\" class=\"abstract_t\">104,105</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Other theories</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is some evidence that central obesity increases intra-abdominal pressure, pleural pressure, cardiac filling pressure, and central venous pressure and may lead to increased intracranial venous pressure and IIH [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/106\" class=\"abstract_t\">106</a>]. Limited support for this theory comes from a report of seven obese women with IIH who reported subjective symptom relief with the use of an externally applied device that lowered abdominal pressure [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/107\" class=\"abstract_t\">107</a>]. However, this mechanism does not account for the gender difference in IIH, the lack of increased incidence in pregnancy, and the cases of IIH in thin patients [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/108,109\" class=\"abstract_t\">108,109</a>].</p><p>Cerebral edema was one of the earliest proposed mechanisms for IIH and had pathologic support in one case series [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/110\" class=\"abstract_t\">110</a>]. However, subsequent pathologic and MRI studies have not found evidence of cerebral edema in patients with IIH [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/111-114\" class=\"abstract_t\">111-114</a>]. A link between IIH and altered sodium and water retention was suggested by another report in which 77 percent of IIH patients had evidence of peripheral edema and 80 percent had orthostatic retention of sodium and water [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/115\" class=\"abstract_t\">115</a>]. Impaired saline and water load excretions were noted in the upright posture in IIH patients with orthostatic edema compared to lean and obese controls without IIH. However, the precise mechanisms linking orthostatic changes and IIH were not defined, and many IIH patients do not have these sodium and water abnormalities.</p><p>Reports of IIH occurring in association with <a href=\"topic.htm?path=vitamin-a-drug-information\" class=\"drug drug_general\">vitamin A</a> intoxication have suggested a role for vitamin A in the pathogenesis of IIH [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/39,49\" class=\"abstract_t\">39,49</a>]. Elevated serum vitamin A, retinol, and retinol binding protein levels have been reported in some, but not all IIH patients [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/116,117\" class=\"abstract_t\">116,117</a>]. In other studies, higher CSF vitamin A, retinol, and retinol binding protein levels have been found in IIH patients compared with controls [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/118-120\" class=\"abstract_t\">118-120</a>]. The significance of these findings remains unknown. One theory suggests that excess retinol or retinol binding protein in the CSF interferes with CSF resorption.</p><p>Other causes of impaired CSF absorption or increased CSF production have also been postulated as an etiology of IIH. As an example, one hypothesis proposes that microthrombosis in the sagittal sinus may block CSF absorption in the arachnoid granulations there even in the absence of a thrombosis of sufficient size to be seen on neuroimaging studies [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/80,121\" class=\"abstract_t\">80,121</a>]. However, most known causes of impaired CSF absorption (after subarachnoid hemorrhage or infectious meningitis) and CSF overproduction (choroid plexus papilloma) produce hydrocephalus, which is not seen in IIH [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/122\" class=\"abstract_t\">122</a>].</p><p>Sleep apnea can be a complication of obesity, and may play a role in IIH, perhaps in men in particular [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/18,123\" class=\"abstract_t\">18,123</a>]. Hypercarbia may produce elevated ICP through vasodilation. Papilledema, but rarely IIH, is common in patients with sleep apnea. One study found that 14 of 37 patients with IIH had a sleep disturbance, and of these, 13 had evidence of sleep apnea or upper airway resistance syndrome [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/74\" class=\"abstract_t\">74</a>]. In another report, a patient with IIH underwent ICP monitoring with pulse oximetry to reveal that apneic episodes were associated with marked elevations of ICP [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/124\" class=\"abstract_t\">124</a>].</p><p>Several studies have looked at the pathophysiology of obesity and its complications as a basis for IIH. Leptin is a protein secreted by adipose cells, in proportion to total body fat content. Higher serum leptin levels were found in 15 obese IIH patients compared to 16 obese and 15 non-obese controls [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/125\" class=\"abstract_t\">125</a>]. The pathophysiologic consequences of this finding are not known. Other studies of other adipokines and the gastric hormone, ghrelin, have not consistently found an association of these with IIH [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/121,126\" class=\"abstract_t\">121,126</a>].</p><p>Few studies have examined the potential role of sex hormones in IIH. In one study of eight men with IIH, two had abnormal estradiol levels, four had abnormal follicle stimulating and luteinizing hormone levels, and seven had low testosterone levels [<a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/127\" class=\"abstract_t\">127</a>].</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=idiopathic-intracranial-hypertension-pseudotumor-cerebri-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Idiopathic intracranial hypertension (pseudotumor cerebri) (The Basics)&quot;</a>)</p><p/><p/><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">SUMMARY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Idiopathic intracranial hypertension (IIH) is a disorder defined by clinical criteria that include symptoms and signs isolated to those produced by increased intracranial pressure (eg, headache, papilledema, vision loss), elevated intracranial pressure with normal cerebrospinal fluid composition, and no other cause of intracranial hypertension evident on neuroimaging or other evaluations.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The incidence of IIH in the general population is 1 to 2 per 100,000, and is 2 to 20 times higher in the primary risk group: overweight women of childbearing years. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In prepubertal children, female gender and obesity do not appear to be risk factors for IIH. (See <a href=\"#H3\" class=\"local\">'Risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A long list of medications have been reported to be associated with IIH. The evidence linking growth hormone treatment, retinoids, and <a href=\"topic.htm?path=tetracycline-drug-information\" class=\"drug drug_general\">tetracycline</a> antibiotics is strongest; however, the mechanisms by which these might produce IIH is not known. (See <a href=\"#H5\" class=\"local\">'Medications'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other than obesity, the association between other medical conditions and IIH is not proven. (See <a href=\"#H6\" class=\"local\">'Systemic illnesses'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The pathogenesis of IIH is unknown. Much attention has been placed on the association of IIH with venous sinus stenosis. However, most of the evidence at present suggests that apparent venous sinus narrowing is secondary to increased intracranial pressure and is not the primary cause in most cases. (See <a href=\"#H8\" class=\"local\">'Intracranial venous hypertension'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other theories include increased cerebrospinal fluid outflow resistance; obesity-related increased abdominal and intracranial venous pressure; altered sodium and water retention mechanisms; and abnormalities of <a href=\"topic.htm?path=vitamin-a-drug-information\" class=\"drug drug_general\">vitamin A</a> metabolism. (See <a href=\"#H9\" class=\"local\">'Other theories'</a> above.)</p><p/><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/1\" class=\"nounderline abstract_t\">Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59:1492.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/2\" class=\"nounderline abstract_t\">Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988; 45:875.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/3\" class=\"nounderline abstract_t\">Radhakrishnan K, Ahlskog JE, Cross SA, et al. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993; 50:78.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/4\" class=\"nounderline abstract_t\">Kesler A, Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 2001; 21:12.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/5\" class=\"nounderline abstract_t\">Curry WT Jr, Butler WE, Barker FG 2nd. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery 2005; 57:97.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/6\" class=\"nounderline abstract_t\">Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982; 39:461.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/7\" class=\"nounderline abstract_t\">Ireland B, Corbett JJ, Wallace RB. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol 1990; 47:315.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/8\" class=\"nounderline abstract_t\">Jain N, Rosner F. Idiopathic intracranial hypertension: report of seven cases. Am J Med 1992; 93:391.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/9\" class=\"nounderline abstract_t\">Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991; 114 ( Pt 1A):155.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/10\" class=\"nounderline abstract_t\">Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991; 41:239.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/11\" class=\"nounderline abstract_t\">Kesler A, Goldhammer Y, Gadoth N. Do men with pseudomotor cerebri share the same characteristics as women? A retrospective review of 141 cases. J Neuroophthalmol 2001; 21:15.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/12\" class=\"nounderline abstract_t\">Bruce BB, Preechawat P, Newman NJ, et al. Racial differences in idiopathic intracranial hypertension. Neurology 2008; 70:861.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/13\" class=\"nounderline abstract_t\">Galvin JA, Van Stavern GP. Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center. J Neurol Sci 2004; 223:157.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/14\" class=\"nounderline abstract_t\">Bruce BB, Kedar S, Van Stavern GP, et al. Atypical idiopathic intracranial hypertension: normal BMI and older patients. Neurology 2010; 74:1827.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/15\" class=\"nounderline abstract_t\">Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 2014; 71:693.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/16\" class=\"nounderline abstract_t\">Soler D, Cox T, Bullock P, et al. Diagnosis and management of benign intracranial hypertension. Arch Dis Child 1998; 78:89.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/17\" class=\"nounderline abstract_t\">Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol 1988; 45:866.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/18\" class=\"nounderline abstract_t\">Lee AG, Golnik K, Kardon R, et al. Sleep apnea and intracranial hypertension in men. Ophthalmology 2002; 109:482.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/19\" class=\"nounderline abstract_t\">Johnston I, Kollar C, Dunkley S, et al. Cranial venous outflow obstruction in the pseudotumour syndrome: incidence, nature and relevance. J Clin Neurosci 2002; 9:273.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/20\" class=\"nounderline abstract_t\">Balcer LJ, Liu GT, Forman S, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999; 52:870.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/21\" class=\"nounderline abstract_t\">Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999; 127:178.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/22\" class=\"nounderline abstract_t\">Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci 1997; 24:219.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/23\" class=\"nounderline abstract_t\">Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 1992; 37:155.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/24\" class=\"nounderline abstract_t\">Scott IU, Siatkowski RM, Eneyni M, et al. Idiopathic intracranial hypertension in children and adolescents. Am J Ophthalmol 1997; 124:253.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/25\" class=\"nounderline abstract_t\">Genizi J, Lahat E, Zelnik N, et al. Childhood-onset idiopathic intracranial hypertension: relation of sex and obesity. Pediatr Neurol 2007; 36:247.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/26\" class=\"nounderline abstract_t\">Warman R. Management of pseudotumor cerebri in children. Int Pediatr 2000; 15:147.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/27\" class=\"nounderline abstract_t\">Distelmaier F, Sengler U, Messing-Juenger M, et al. Pseudotumor cerebri as an important differential diagnosis of papilledema in children. Brain Dev 2006; 28:190.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/28\" class=\"nounderline abstract_t\">Per H, Canpolat M, G&uuml;m&uuml;&#351; H, et al. Clinical spectrum of the pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis. Brain Dev 2013; 35:561.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/29\" class=\"nounderline abstract_t\">Bandyopadhyay S, Jacobson DM. Clinical features of late-onset pseudotumor cerebri fulfilling the modified dandy criteria. J Neuroophthalmol 2002; 22:9.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/30\" class=\"nounderline abstract_t\">Salpietro V, Chimenz R, Arrigo T, Ruggieri M. Pediatric idiopathic intracranial hypertension and extreme childhood obesity: a role for weight gain. J Pediatr 2013; 162:1084.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/31\" class=\"nounderline abstract_t\">Blethen SL. Complications of growth hormone therapy in children. Curr Opin Pediatr 1995; 7:466.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/32\" class=\"nounderline abstract_t\">Francois I, Casteels I, Silberstein J, et al. Empty sella, growth hormone deficiency and pseudotumour cerebri: effect of initiation, withdrawal and resumption of growth hormone therapy. Eur J Pediatr 1997; 156:69.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/33\" class=\"nounderline abstract_t\">Koller EA, Stadel BV, Malozowski SN. Papilledema in 15 renally compromised patients treated with growth hormone. Pediatr Nephrol 1997; 11:451.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/34\" class=\"nounderline abstract_t\">Malozowski S, Tanner LA, Wysowski DK, et al. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr 1995; 126:996.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/35\" class=\"nounderline abstract_t\">Rogers AH, Rogers GL, Bremer DL, McGregor ML. Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology 1999; 106:1186.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/36\" class=\"nounderline abstract_t\">Maneatis T, Baptista J, Connelly K, Blethen S. Growth hormone safety update from the National Cooperative Growth Study. J Pediatr Endocrinol Metab 2000; 13 Suppl 2:1035.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/37\" class=\"nounderline abstract_t\">Reeves GD, Doyle DA. Growth hormone treatment and pseudotumor cerebri: coincidence or close relationship? J Pediatr Endocrinol Metab 2002; 15 Suppl 2:723.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/38\" class=\"nounderline abstract_t\">Vischi A, Guerriero S, Giancipoli G, et al. Delayed onset of pseudotumor cerebri syndrome 7 years after starting human recombinant growth hormone treatment. Eur J Ophthalmol 2006; 16:178.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/39\" class=\"nounderline abstract_t\">Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol 2005; 6:29.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/40\" class=\"nounderline abstract_t\">Moskowitz Y, Leibowitz E, Ronen M, Aviel E. Pseudotumor cerebri induced by vitamin A combined with minocycline. Ann Ophthalmol 1993; 25:306.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/41\" class=\"nounderline abstract_t\">Sirdofsky M, Kattah J, Macedo P. Intracranial hypertension in a dieting patient. J Neuroophthalmol 1994; 14:9.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/42\" class=\"nounderline abstract_t\">Ang ER, Zimmerman JC, Malkin E. Pseudotumor cerebri secondary to minocycline intake. J Am Board Fam Pract 2002; 15:229.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/43\" class=\"nounderline abstract_t\">Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998; 126:116.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/44\" class=\"nounderline abstract_t\">Friedman DI, Gordon LK, Egan RA, et al. Doxycycline and intracranial hypertension. Neurology 2004; 62:2297.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/45\" class=\"nounderline abstract_t\">Gardner K, Cox T, Digre KB. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case reports and review. Neurology 1995; 45:6.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/46\" class=\"nounderline abstract_t\">Kesler A, Goldhammer Y, Hadayer A, Pianka P. The outcome of pseudotumor cerebri induced by tetracycline therapy. Acta Neurol Scand 2004; 110:408.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/47\" class=\"nounderline abstract_t\">Mochizuki K, Takahashi T, Kano M, et al. Pseudotumor cerebri induced by minocycline therapy for acne vulgaris. Jpn J Ophthalmol 2002; 46:668.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/48\" class=\"nounderline abstract_t\">Fraser CL, Biousse V, Newman NJ. Minocycline-induced fulminant intracranial hypertension. Arch Neurol 2012; 69:1067.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/49\" class=\"nounderline abstract_t\">Donahue SP. Recurrence of idiopathic intracranial hypertension after weight loss: the carrot craver. Am J Ophthalmol 2000; 130:850.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/50\" class=\"nounderline abstract_t\">Alemayehu W. Pseudotumor cerebri (toxic effect of the &quot;magic bullet&quot;). Ethiop Med J 1995; 33:265.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/51\" class=\"nounderline abstract_t\">Sharieff GQ, Hanten K. Pseudotumor cerebri and hypercalcemia resulting from vitamin A toxicity. Ann Emerg Med 1996; 27:518.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/52\" class=\"nounderline abstract_t\">Colucciello M. Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia. Arch Ophthalmol 2003; 121:1064.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/53\" class=\"nounderline abstract_t\">Yeh YC, Tang HF, Fang IM. Pseudotumor cerebri caused by all-trans-retinoic acid treatment for acute promyelocytic leukemia. Jpn J Ophthalmol 2006; 50:295.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/54\" class=\"nounderline abstract_t\">Fraunfelder FW, Fraunfelder FT, Corbett JJ. Isotretinoin-associated intracranial hypertension. Ophthalmology 2004; 111:1248.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/55\" class=\"nounderline abstract_t\">Serratrice J, Granel B, Conrath J, et al. Benign intracranial hypertension and thyreostimulin suppression hormonotherapy. Am J Ophthalmol 2002; 134:910.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/56\" class=\"nounderline abstract_t\">Campos SP, Olitsky S. Idiopathic intracranial hypertension after L-thyroxine therapy for acquired primary hypothyroidism. Clin Pediatr (Phila) 1995; 34:334.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/57\" class=\"nounderline abstract_t\">Raghavan S, DiMartino-Nardi J, Saenger P, Linder B. Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism. J Pediatr 1997; 130:478.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/58\" class=\"nounderline abstract_t\">Liu GT, Kay MD, Bienfang DC, Schatz NJ. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol 1994; 117:352.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/59\" class=\"nounderline abstract_t\">Rickels MR, Nichols CW. Pseudotumor cerebri in patients with Cushing's disease. Endocr Pract 2004; 10:492.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/60\" class=\"nounderline abstract_t\">Ames D, Wirshing WC, Cokely HT, Lo LL. The natural course of pseudotumor cerebri in lithium-treated patients. J Clin Psychopharmacol 1994; 14:286.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/61\" class=\"nounderline abstract_t\">Dommisse J. Pseudotumor cerebri associated with lithium therapy in two patients. J Clin Psychiatry 1991; 52:239.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/62\" class=\"nounderline abstract_t\">Hexom B, Barthel RP. Lithium and pseudotumor cerebri. J Am Acad Child Adolesc Psychiatry 2004; 43:247.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/63\" class=\"nounderline abstract_t\">Levine SH, Puchalski C. Pseudotumor cerebri associated with lithium therapy in two patients. J Clin Psychiatry 1990; 51:251.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/64\" class=\"nounderline abstract_t\">Mukherjee A, Dutta P, Lahiri M, et al. Benign intracranial hypertension after nalidixic acid overdose in infants. Lancet 1990; 335:1602.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/65\" class=\"nounderline abstract_t\">Mushet GR. Pseudotumor and nitrofurantoin therapy. Arch Neurol 1977; 34:257.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/66\" class=\"nounderline abstract_t\">Francis PJ, Haywood S, Rigden S, et al. Benign intracranial hypertension in children following renal transplantation. Pediatr Nephrol 2003; 18:1265.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/67\" class=\"nounderline abstract_t\">Condulis N, Germain G, Charest N, et al. Pseudotumor cerebri: a presenting manifestation of Addison's disease. Clin Pediatr (Phila) 1997; 36:711.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/68\" class=\"nounderline abstract_t\">Alexandrakis G, Filatov V, Walsh T. Pseudotumor cerebri in a 12-year-old boy with Addison's disease. Am J Ophthalmol 1993; 116:650.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/69\" class=\"nounderline abstract_t\">Sheldon RS, Becker WJ, Hanley DA, Culver RL. Hypoparathyroidism and pseudotumor cerebri: an infrequent clinical association. Can J Neurol Sci 1987; 14:622.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/70\" class=\"nounderline abstract_t\">Biousse V, Rucker JC, Vignal C, et al. Anemia and papilledema. Am J Ophthalmol 2003; 135:437.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/71\" class=\"nounderline abstract_t\">Segal L, Discepola M. Idiopathic intracranial hypertension and sickle cell disease: two case reports. Can J Ophthalmol 2005; 40:764.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/72\" class=\"nounderline abstract_t\">Nazir SA, Siatkowski RM. Pseudotumor cerebri in idiopathic aplastic anemia. J AAPOS 2003; 7:71.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/73\" class=\"nounderline abstract_t\">Purvin VA, Kawasaki A, Yee RD. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol 2000; 118:1626.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/74\" class=\"nounderline abstract_t\">Marcus DM, Lynn J, Miller JJ, et al. Sleep disorders: a risk factor for pseudotumor cerebri? J Neuroophthalmol 2001; 21:121.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/75\" class=\"nounderline abstract_t\">Dave S, Longmuir R, Shah VA, et al. Intracranial hypertension in systemic lupus erythematosus. Semin Ophthalmol 2008; 23:127.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/76\" class=\"nounderline abstract_t\">Hershko AY, Berkun Y, Mevorach D, et al. Increased intracranial pressure related to systemic lupus erythematosus: a 26-year experience. Semin Arthritis Rheum 2008; 38:110.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/77\" class=\"nounderline abstract_t\">Green L, Vinker S, Amital H, et al. Pseudotumor cerebri in systemic lupus erythematosus. Semin Arthritis Rheum 1995; 25:103.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/78\" class=\"nounderline abstract_t\">Celebisoy N, Se&ccedil;il Y, Aky&uuml;rekli O. Pseudotumor cerebri: etiological factors, presenting features and prognosis in the western part of Turkey. Acta Neurol Scand 2002; 106:367.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/79\" class=\"nounderline abstract_t\">Palacio E, Rodero L, Pascual J. Topiramate-responsive headache due to idiopathic intracranial hypertension in Beh&ccedil;et syndrome. Headache 2004; 44:436.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/80\" class=\"nounderline abstract_t\">Glueck CJ, Iyengar S, Goldenberg N, et al. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome. J Lab Clin Med 2003; 142:35.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/81\" class=\"nounderline abstract_t\">Kesler A, Ellis MH, Reshef T, et al. Idiopathic intracranial hypertension and anticardiolipin antibodies. J Neurol Neurosurg Psychiatry 2000; 68:379.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/82\" class=\"nounderline abstract_t\">Leker RR, Steiner I. Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension. Arch Neurol 1998; 55:817.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/83\" class=\"nounderline abstract_t\">Sussman J, Leach M, Greaves M, et al. Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension. J Neurol Neurosurg Psychiatry 1997; 62:229.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/84\" class=\"nounderline abstract_t\">Chang D, Nagamoto G, Smith WE. Benign intracranial hypertension and chronic renal failure. Cleve Clin J Med 1992; 59:419.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/85\" class=\"nounderline abstract_t\">Dotan G, Goldstein M, Stolovitch C, Kesler A. Pediatric Pseudotumor Cerebri Associated With Low Serum Levels of Vitamin A. J Child Neurol 2013; 28:1370.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/86\" class=\"nounderline abstract_t\">Obeid M, Price J, Sun L, et al. Facial palsy and idiopathic intracranial hypertension in twins with cystic fibrosis and hypovitaminosis A. Pediatr Neurol 2011; 44:150.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/87\" class=\"nounderline abstract_t\">Panozzo G, Babighian S, Bonora A. Association of xerophthalmia, flecked retina, and pseudotumor cerebri caused by hypovitaminosis A. Am J Ophthalmol 1998; 125:708.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/88\" class=\"nounderline abstract_t\">Lucidi V, Di Capua M, Rosati P, et al. Benign intracranial hypertension in an older child with cystic fibrosis. Pediatr Neurol 1993; 9:494.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/89\" class=\"nounderline abstract_t\">Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2012; 83:488.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/90\" class=\"nounderline abstract_t\">Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999; 53:1537.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/91\" class=\"nounderline abstract_t\">Lin A, Foroozan R, Danesh-Meyer HV, et al. Occurrence of cerebral venous sinus thrombosis in patients with presumed idiopathic intracranial hypertension. Ophthalmology 2006; 113:2281.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/92\" class=\"nounderline abstract_t\">Tehindrazanarivelo A, Evrard S, Schaison M, et al. Prospective study of cerebral sinus venous thrombosis in patients presenting with benign intracranial hypertension. Cerebrovasc Dis 1992; 2:22.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/93\" class=\"nounderline abstract_t\">Lee AG, Brazis PW. Magnetic resonance venography in idiopathic pseudotumor cerebri. J Neuroophthalmol 2000; 20:12.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/94\" class=\"nounderline abstract_t\">Higgins JN, Tipper G, Varley M, Pickard JD. Transverse sinus stenoses in benign intracranial hypertension demonstrated on CT venography. Br J Neurosurg 2005; 19:137.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/95\" class=\"nounderline abstract_t\">Bono F, Lupo MR, Lavano A, et al. Cerebral MR venography of transverse sinuses in subjects with normal CSF pressure. Neurology 2003; 61:1267.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/96\" class=\"nounderline abstract_t\">Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003; 60:1418.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/97\" class=\"nounderline abstract_t\">King JO, Mitchell PJ, Thomson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002; 58:26.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/98\" class=\"nounderline abstract_t\">Simister R, Bowler JV, Wilson PL, et al. Transverse venous sinus stenosis and intracranial hypertension: evidence for which comes first. J Neurol 2008; 255:601.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/99\" class=\"nounderline abstract_t\">McGonigal A, Bone I, Teasdale E. Resolution of transverse sinus stenosis in idiopathic intracranial hypertension after L-P shunt. Neurology 2004; 62:514.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/100\" class=\"nounderline abstract_t\">Higgins JN, Pickard JD. Lateral sinus stenoses in idiopathic intracranial hypertension resolving after CSF diversion. Neurology 2004; 62:1907.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/101\" class=\"nounderline abstract_t\">Rohr A, D&ouml;rner L, Stingele R, et al. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2007; 28:656.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/102\" class=\"nounderline abstract_t\">De Simone R, Marano E, Fiorillo C, et al. Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci 2005; 25:342.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/103\" class=\"nounderline abstract_t\">Baryshnik DB, Farb RI. Changes in the appearance of venous sinuses after treatment of disordered intracranial pressure. Neurology 2004; 62:1445.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/104\" class=\"nounderline abstract_t\">Bono F, Giliberto C, Mastrandrea C, et al. Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology 2005; 65:1090.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/105\" class=\"nounderline abstract_t\">Riggeal BD, Bruce BB, Saindane AM, et al. Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 2013; 80:289.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/106\" class=\"nounderline abstract_t\">Sugerman HJ, DeMaria EJ, Felton WL 3rd, et al. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology 1997; 49:507.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/107\" class=\"nounderline abstract_t\">Sugerman HJ, Felton III WL 3rd, Sismanis A, et al. Continuous negative abdominal pressure device to treat pseudotumor cerebri. Int J Obes Relat Metab Disord 2001; 25:486.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/108\" class=\"nounderline abstract_t\">Friedman DI. Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol 2006; 26:61.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/109\" class=\"nounderline abstract_t\">Digre KB, Varner MW, Corbett JJ. Pseudotumor cerebri and pregnancy. Neurology 1984; 34:721.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/110\" class=\"nounderline abstract_t\">Sahs AL, Joynt RJ. Brain swelling of unknown cause. Neurology 1954; 6:791.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/111\" class=\"nounderline abstract_t\">Wall M, Dollar JD, Sadun AA, Kardon R. Idiopathic intracranial hypertension. Lack of histologic evidence for cerebral edema. Arch Neurol 1995; 52:141.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/112\" class=\"nounderline abstract_t\">Bastin ME, Sinha S, Farrall AJ, et al. Diffuse brain oedema in idiopathic intracranial hypertension: a quantitative magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 2003; 74:1693.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/113\" class=\"nounderline abstract_t\">Bicakci K, Bicakci S, Aksungur E. Perfusion and diffusion magnetic resonance imaging in idiopathic intracranial hypertension. Acta Neurol Scand 2006; 114:193.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/114\" class=\"nounderline abstract_t\">Owler BK, Higgins JN, P&eacute;na A, et al. Diffusion tensor imaging of benign intracranial hypertension: absence of cerebral oedema. Br J Neurosurg 2006; 20:79.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/115\" class=\"nounderline abstract_t\">Friedman DI, Streeten DH. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology 1998; 50:1099.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/116\" class=\"nounderline abstract_t\">Jacobson DM, Berg R, Wall M, et al. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology 1999; 53:1114.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/117\" class=\"nounderline abstract_t\">Selhorst JB, Kulkantrakorn K, Corbett JJ, et al. Retinol-binding protein in idiopathic intracranial hypertension (IIH). J Neuroophthalmol 2000; 20:250.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/118\" class=\"nounderline abstract_t\">Warner JE, Bernstein PS, Yemelyanov A, et al. Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol 2002; 52:647.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/119\" class=\"nounderline abstract_t\">Tabassi A, Salmasi AH, Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 2005; 64:1893.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/120\" class=\"nounderline abstract_t\">Warner JE, Larson AJ, Bhosale P, et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol 2007; 27:258.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/121\" class=\"nounderline abstract_t\">Ooi LY, Walker BR, Bodkin PA, Whittle IR. Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogenesis? Br J Neurosurg 2008; 22:187.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/122\" class=\"nounderline abstract_t\">Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia 2006; 26:384.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/123\" class=\"nounderline abstract_t\">Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology 2009; 72:304.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/124\" class=\"nounderline abstract_t\">Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997; 49:734.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/125\" class=\"nounderline abstract_t\">Lampl Y, Eshel Y, Kessler A, et al. Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2002; 72:642.</a></li><li><a href=\"https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis/abstract/126\" class=\"nounderline abstract_t\">Subramanian PS, Goldenberg-Cohen N, Shukla S, et al. Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2004; 138:109.</a></li><li class=\"breakAll\">Lee A, Kardon R, Wall M, Schlechte J. Endocrinologic abnormalities in pseudotumor cerebri in men. In: 28th Annual North American Neuro-Ophthalmology Society Meeting, Copper Mountain, CO 2002.</li></ol></div><div id=\"topicVersionRevision\">Topic 5254 Version 10.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H10\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a><ul><li><a href=\"#H456571163\" id=\"outline-link-H456571163\">Incidence</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">Risk factors</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Associated conditions</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">- Medications</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">- Systemic illnesses</a></li></ul></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">PATHOGENESIS</a><ul><li><a href=\"#H8\" id=\"outline-link-H8\">Intracranial venous hypertension</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Other theories</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H2401016\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=idiopathic-intracranial-hypertension-pseudotumor-cerebri-clinical-features-and-diagnosis\" class=\"medical medical_review\">Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=idiopathic-intracranial-hypertension-pseudotumor-cerebri-prognosis-and-treatment\" class=\"medical medical_review\">Idiopathic intracranial hypertension (pseudotumor cerebri): Prognosis and treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=idiopathic-intracranial-hypertension-pseudotumor-cerebri-the-basics\" class=\"medical medical_basics\">Patient education: Idiopathic intracranial hypertension (pseudotumor cerebri) (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-growth-hormone-deficiency-in-children\" class=\"medical medical_review\">Treatment of growth hormone deficiency in children</a></li></ul></div></div>","javascript":null}